Skip to main content
logo
Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China flag China · Delayed Price · Currency is CNY
10.26
+0.77 (8.11%)
Nov 2, 2026, 3:04 PM CST

SHE:300439 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
100.5163.2258256.55198.53179.49
Depreciation & Amortization
158.87163.26210.21169.63191.67194.82
Other Amortization
26.9922.6112.6515.1119.9733.12
Loss (Gain) From Sale of Assets
-1.66-1.660.670.780.32-0.48
Asset Writedown & Restructuring Costs
0.30.32.210.8713.14.03
Loss (Gain) From Sale of Investments
3.33.3-3.34-11.335.9815.98
Provision & Write-off of Bad Debts
5.35.3-19.73-4.2840.9821.85
Other Operating Activities
-109.0822.8415.18-6.8641.6948.81
Change in Accounts Receivable
-64.04-64.0416.71206.66-76.76-147.18
Change in Inventory
33.8533.85-33.6-58.02-20.7115.31
Change in Accounts Payable
41.6141.61-67.1834.98179.33159.07
Change in Other Net Operating Assets
7.137.1313.3316.57-19.2-0.73
Operating Cash Flow
172266.61397.81633.53564.67515.48
Operating Cash Flow Growth
-60.35%-32.98%-37.21%12.20%9.54%-43.48%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-152.67-191.41-420.54-280.37-303.13-201.82
Sale of Property, Plant & Equipment
5.115.1934.3223.457.3127.13
Divestitures
0.170.3623.9763.6633.555.2
Investment in Securities
-307.25-93.72-183.7918.8121.13-47.35
Other Investing Activities
11.0421.2218.9312.388.6629.27
Investing Cash Flow
-443.6-258.35-527.11-162.08-232.49-187.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Short-Term Debt Issued
-34.843050-1.5
Long-Term Debt Issued
----212.65410.95
Total Debt Issued
94.8434.843050212.65412.45
Short-Term Debt Repaid
--45-57.04-278.04--1.5
Long-Term Debt Repaid
--15.69-16.84-18.57-383.19-883.43
Lease Payments
-15.69-15.69-16.84-18.57-21.3-19.37
Total Debt Repaid
-50.69-60.69-73.88-296.61-383.19-884.93
Net Debt Issued (Repaid)
44.16-25.84-43.88-246.61-170.55-472.49
Issuance of Common Stock
-2.21---586.6
Common Dividends Paid
-12.04-51.99-52.47-49.88-50.71-91.39
Other Financing Activities
-2.25-1.09-0.06-7.040.181.47
Financing Cash Flow
29.87-76.71-96.42-303.52-221.0724.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-0.89-0.730.010.54-1.580.93
Net Cash Flow
-242.62-69.18-225.71168.47109.52353.06

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
19.3275.21-22.73353.16261.53313.67
Free Cash Flow Growth
-83.30%--35.04%-16.62%-40.66%
Free Cash Flow Margin
1.15%4.89%-1.30%18.73%10.51%13.93%
Free Cash Flow Per Share
0.050.19-0.060.920.690.84
Levered Free Cash Flow
9.08-25.06-46.86238.63138.27245.86
Unlevered Free Cash Flow
9.97-23.46-45.28245.29148.04264.15
Free Cash Flow After Leases
3.6359.52-39.57334.6240.23294.3

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
82.8989.8698.26132.25129.64128.04
Change in Working Capital
-12.54-12.54-78.02203.0552.4117.87